Showing results (11-20 of 24) with videos related to
Sort By:
Pageof 3
American Journal of Clinical Oncology|March 17, 2017
Influence of Extent of Lymph Node Evaluation on Survival for Pathologically Lymph Node Negative Non-Small Cell Lung CancerDaniel J Becker, Benjamin P Levy, Heather T Gold, et al.Future Oncology (London, England)|May 30, 2023
TROPION-Lung08: phase III study of datopotamab deruxtecan plus pembrolizumab as first-line therapy for advanced NSCLCBenjamin P Levy, Enriqueta Felip, Martin Reck, et al.The Oncologist|September 3, 2015
Molecular Testing for Treatment of Metastatic Non-Small Cell Lung Cancer: How to Implement Evidence-Based RecommendationsBenjamin P Levy, Marc D Chioda, Dana Herndon, et al.JTO Clinical and Research Reports|July 8, 2024
First-line Osimertinib for Lung Cancer With Uncommon EGFR Exon 19 Mutations and EGFR Compound MutationsTia Cheunkarndee, Matthew Z Guo, Stefanie Houseknecht, et al.Cancer Research|July 30, 2011
Taxane-induced blockade to nuclear accumulation of the androgen receptor predicts clinical responses in metastatic prostate cancerMedha S Darshan, Matthew S Loftus, Maria Thadani-Mulero, et al.Clinical Lung Cancer|August 31, 2022
Definitive Chemoradiation and Durvalumab Consolidation for Locally Advanced, Unresectable KRAS-mutated Non-Small Cell Lung CancerMatthew Z Guo, Joseph C Murray, Paola Ghanem, et al.European Journal of Cancer (Oxford, England : 1990)|January 18, 2019
Randomised phase 2 study of pembrolizumab plus CC-486 versus pembrolizumab plus placebo in patients with previously treated advanced non-small cell lung cancerBenjamin P Levy, Giuseppe Giaccone, Benjamin Besse, et al.RMD Open|November 1, 2023
Improved lung cancer clinical outcomes in patients with autoimmune rheumatic diseasesPaola Ghanem, Joseph C Murray, Kristen A Marrone, et al.Journal of Neurosurgery|June 4, 2021
Mutation status and postresection survival of patients with non-small cell lung cancer brain metastasis: implications of biomarker-driven therapyPavan P Shah, Jennifer L Franke, Ravi Medikonda, et al.Frontiers in Oncology|August 22, 2022
Sex-specific differences in immunogenomic features of response to immune checkpoint blockadeSusan C Scott, Xiaoshan M Shao, Noushin Niknafs, et al.Pageof 3